Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
E.W. SCRIPPS Co
13G
SSP · 811054402
|
5.2% |
10/5/2026
Event 10/2/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Viridian Therapeutics, Inc.
13G
VRDN · 92790C104
|
5.0% |
8/20/2026
Event 8/19/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
RxSight, Inc.
13G
RXST · 78349D107
|
6.0% |
8/19/2026
Event 8/12/2026
|
|||
| Point72 Asset Management, L.P. | 6.0% | ||||
| Point72 Capital Advisors, Inc. | 6.0% | ||||
| Steven A. Cohen | 6.0% | ||||
|
Neuronetics, Inc.
13G
STIM · 64131A105
|
5.0% |
8/14/2026
Event 8/13/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Zepp Health Corp
13G/A
Amendment 2
ZEPP · 98945L204
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
VNET Group, Inc.
13G/A
Amendment 1
VNET · 90138A103
|
6.6% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 6.6% | ||||
| Point72 Capital Advisors, Inc. | 6.6% | ||||
| Steven A. Cohen | 6.6% | ||||
|
Sweetgreen, Inc.
13G/A
Amendment 1
SG · 87043Q108
|
3.3% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 3.3% | ||||
| Point72 Capital Advisors, Inc. | 3.3% | ||||
| Steven A. Cohen | 3.3% | ||||
|
Sutro Biopharma, Inc.
13G/A
Amendment 1
STRO · 869367201
|
1.4% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 1.4% | ||||
| Point72 Capital Advisors, Inc. | 1.4% | ||||
| Steven A. Cohen | 1.4% | ||||
|
Q32 Bio Inc.
13G/A
Amendment 2
QTTB · 746964105
|
4.95% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 4.95% | ||||
| Point72 Capital Advisors, Inc. | 4.95% | ||||
| Steven A. Cohen | 4.95% | ||||
|
Power Solutions International, Inc.
13G/A
Amendment 1
PSIX · 73933G202
|
6.5% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 6.5% | ||||
| Point72 Capital Advisors, Inc. | 6.5% | ||||
| Steven A. Cohen | 6.5% | ||||
|
Janux Therapeutics, Inc.
13G/A
Amendment 1
JANX · 47103J105
|
3.3% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 3.3% | ||||
| Point72 Capital Advisors, Inc. | 3.3% | ||||
| Steven A. Cohen | 3.3% | ||||
|
HMH Holding Inc
13G/A
Amendment 1
HMH · 40445M100
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Design Therapeutics, Inc.
13G/A
Amendment 1
DSGN · 25056L103
|
3.8% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 3.8% | ||||
| Point72 Capital Advisors, Inc. | 3.8% | ||||
| Steven A. Cohen | 3.8% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 1
CTMX · 23284F105
|
3.6% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 3.6% | ||||
| Point72 Capital Advisors, Inc. | 3.6% | ||||
| Steven A. Cohen | 3.6% | ||||
|
Atara Biotherapeutics, Inc.
13G/A
Amendment 1
ATRA · 046513206
|
7.6% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 7.6% | ||||
| Point72 Capital Advisors, Inc. | 7.6% | ||||
| Steven A. Cohen | 7.6% | ||||
|
AIB Data Centers Inc.
13G/A
Amendment 1
AIB · 093919108
|
6.6% |
8/14/2026
Event 6/30/2026
|
|||
| Point72 Asset Management, L.P. | 6.6% | ||||
| Point72 Capital Advisors, Inc. | 6.6% | ||||
| Steven A. Cohen | 6.6% | ||||
|
Evommune, Inc.
13G
EVMN · 30054Y107
|
5.3% |
7/16/2026
Event 7/15/2026
|
|||
| Point72 Asset Management, L.P. | 5.3% | ||||
| Point72 Capital Advisors, Inc. | 5.3% | ||||
| Steven A. Cohen | 5.3% | ||||
|
Perceptive Capital Solutions Corp
13G
PCSC · G70077105
|
5.7% |
7/8/2026
Event 7/7/2026
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
BlockchAIn Digital Infrastructure, Inc.
13G
AIB · 093919108
|
5.2% |
6/25/2026
Event 6/24/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Design Therapeutics, Inc.
13G
DSGN · 25056L103
|
5.1% |
6/9/2026
Event 6/8/2026
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Avalo Therapeutics, Inc.
13G
AVTX · 05338F306
|
5.2% |
5/26/2026
Event 5/22/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Power Solutions International, Inc.
13G
PSIX · 73933G202
|
5.0% |
5/22/2026
Event 5/21/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Sweetgreen, Inc.
13G
SG · 87043Q108
|
6.2% |
5/18/2026
Event 5/15/2026
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
IO Biotech, Inc.
13G/A
Amendment 1
IOBTQ · 449778109
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Q32 Bio Inc.
13G/A
Amendment 1
QTTB · 746964105
|
5.7% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
OKYO Pharma Ltd
13G/A
Amendment 1
OKYO · G6724L116
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Precigen, Inc.
13G/A
Amendment 1
PGEN · 74017N105
|
1.9% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 1.9% | ||||
| Point72 Capital Advisors, Inc. | 1.9% | ||||
| Steven A. Cohen | 1.9% | ||||
|
Korro Bio, Inc.
13G/A
Amendment 1
KRRO · 500946108
|
1.9% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Point72 Biotech Private Investments, LLC | 1.9% | ||||
| Differentiated Ventures Investments, LLC | 1.9% | ||||
| 72 Investment Holdings, LLC | 1.9% | ||||
| Steven A. Cohen | 1.9% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 2
TENX · 88032L605
|
3.1% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 3.1% | ||||
| Point72 Capital Advisors, Inc. | 3.1% | ||||
| Steven A. Cohen | 3.1% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 1
FBRX · 34962G208
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Palisade Bio, Inc.
13G/A
Amendment 2
PALI · 696389402
|
0.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0.2% | ||||
| Point72 Capital Advisors, Inc. | 0.2% | ||||
| Steven A. Cohen | 0.2% | ||||
|
Dianthus Therapeutics, Inc. /DE/
13G/A
Amendment 2
DNTH · 252828108
|
1.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 1.2% | ||||
| Point72 Capital Advisors, Inc. | 1.2% | ||||
| Steven A. Cohen | 1.2% | ||||
|
Edesa Biotech, Inc.
13G/A
Amendment 1
EDSA · 27966L306
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Design Therapeutics, Inc.
13G/A
Amendment 2
DSGN · 25056L103
|
4.4% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 4.4% | ||||
| Point72 Capital Advisors, Inc. | 4.4% | ||||
| Steven A. Cohen | 4.4% | ||||
|
Cybin Inc.
13G/A
Amendment 3
HELP · 23256X407
|
1.4% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 1.4% | ||||
| Point72 Capital Advisors, Inc. | 1.4% | ||||
| Steven A. Cohen | 1.4% | ||||
|
Invivyd, Inc.
13G/A
Amendment 3
IVVD · 00534A102
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Xilio Therapeutics, Inc.
13G/A
Amendment 2
XLO · 98422T100
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
KalVista Pharmaceuticals, Inc.
13G/A
Amendment 2
KALV · 483497103
|
4.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 4.2% | ||||
| Point72 Capital Advisors, Inc. | 4.2% | ||||
| Steven A. Cohen | 4.2% | ||||
|
Relay Therapeutics, Inc.
13G/A
Amendment 2
RLAY · 75943R102
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Tonix Pharmaceuticals Holding Corp.
13G/A
Amendment 1
TNXP · 890260839
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 6.9% | ||||
| Point72 Capital Advisors, Inc. | 6.9% | ||||
| Steven A. Cohen | 6.9% | ||||
|
Anaptysbio, Inc
13G/A
Amendment 2
ANAB · 032724106
|
0.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0.2% | ||||
| Point72 Capital Advisors, Inc. | 0.2% | ||||
| Steven A. Cohen | 0.2% | ||||
|
Ovid Therapeutics Inc.
13G/A
Amendment 1
OVID · 690469101
|
1.3% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 1.3% | ||||
| Point72 Capital Advisors, Inc. | 1.3% | ||||
| Steven A. Cohen | 1.3% | ||||
|
Immunome Inc.
13G/A
Amendment 1
IMNM · 45257U108
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
C4 Therapeutics, Inc.
13G/A
Amendment 1
CCCC · 12529R107
|
0.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0.2% | ||||
| Point72 Capital Advisors, Inc. | 0.2% | ||||
| Steven A. Cohen | 0.2% | ||||
|
Damora Therapeutics, Inc.
13G/A
Amendment 1
DMRA · 36322Q206
|
2.0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 2.0% | ||||
| Point72 Capital Advisors, Inc. | 2.0% | ||||
| Steven A. Cohen | 2.0% | ||||
|
iBio, Inc.
13G/A
Amendment 1
IBIO · 451033708
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Century Therapeutics, Inc.
13G/A
Amendment 2
IPSC · 15673T100
|
3.3% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 3.3% | ||||
| Point72 Capital Advisors, Inc. | 3.3% | ||||
| Steven A. Cohen | 3.3% | ||||
|
Syndax Pharmaceuticals Inc
13G/A
Amendment 1
SNDX · 87164F105
|
2.3% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 2.3% | ||||
| Point72 Capital Advisors, Inc. | 2.3% | ||||
| Steven A. Cohen | 2.3% | ||||
|
Palatin Technologies Inc
13G/A
Amendment 1
PTN · 696077601
|
0.5% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0.5% | ||||
| Point72 Capital Advisors, Inc. | 0.5% | ||||
| Steven A. Cohen | 0.5% | ||||
|
Oric Pharmaceuticals, Inc.
13G/A
Amendment 1
ORIC · 68622P109
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Black Rock Coffee Bar, Inc.
13G/A
Amendment 1
BRCB · 092244102
|
4.3% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 4.3% | ||||
| Point72 Capital Advisors, Inc. | 4.3% | ||||
| Steven A. Cohen | 4.3% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 8
PRAX · 74006W207
|
0.2% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Point72 Biotech Private Investments, LLC | 0.2% | ||||
| Differentiated Ventures Investments, LLC | 0.2% | ||||
| 72 Investment Holdings, LLC | 0.2% | ||||
| Steven A. Cohen | 0.2% | ||||
|
Lionsgate Studios Corp.
13G/A
Amendment 1
LION · 53626N102
|
2.4% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 2.4% | ||||
| Point72 Capital Advisors, Inc. | 2.4% | ||||
| Steven A. Cohen | 2.4% | ||||
|
Corvus Pharmaceuticals, Inc.
13G/A
Amendment 1
CRVS · 221015100
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
AngioDynamics, Inc.
13G/A
Amendment 2
ANGO · 03475V101
|
7.7% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 7.7% | ||||
| Point72 Capital Advisors, Inc. | 7.7% | ||||
| Steven A. Cohen | 7.7% | ||||
|
Alto Neuroscience, Inc.
13G/A
Amendment 4
ANRO · 02157Q109
|
3.7% |
5/15/2026
Event 3/31/2026
|
|||
| Point72 Asset Management, L.P. | 1.6% | ||||
| Point72 Capital Advisors, Inc. | 1.6% | ||||
| Point72 Biotech Private Investments, LLC | 2.1% | ||||
| Differentiated Ventures Investments, LLC | 2.1% | ||||
| 72 Investment Holdings, LLC | 2.1% | ||||
| Steven A. Cohen | 3.7% | ||||
|
STAAR Surgical Company
13G
STAA · 852312305
|
5.2% |
5/12/2026
Event 5/11/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Atara Biotherapeutics, Inc.
13G
ATRA · 046513206
|
6.2% |
5/8/2026
Event 5/7/2026
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Sutro Biopharma, Inc.
13G
STRO · 869367201
|
5.7% |
5/1/2026
Event 4/24/2026
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Janux Therapeutics, Inc.
13G
JANX · 47103J105
|
5.0% |
4/29/2026
Event 4/28/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Janux Therapeutics, Inc.
13G
JANX · 47103J105
|
5.0% |
4/29/2026
Event 4/28/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Surrozen, Inc./DE
13G
SRZN · 86889P208
|
5.4% |
4/23/2026
Event 4/22/2026
|
|||
| Point72 Asset Management, L.P. | 5.4% | ||||
| Point72 Capital Advisors, Inc. | 5.4% | ||||
| Steven A. Cohen | 5.4% | ||||
|
CytomX Therapeutics, Inc.
13G
CTMX · 23284F105
|
5.0% |
4/16/2026
Event 4/15/2026
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
HMH Holding Inc
13G
HMH · 40445M100
|
5.5% |
4/6/2026
Event 4/2/2026
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Steven A. Cohen | 5.5% | ||||
|
Kodiak Sciences Inc.
13G
KOD · 50015M109
|
1.0% |
4/2/2026
Event 3/26/2026
|
|||
| Point72 Asset Management, L.P. | 1.0% | ||||
| Point72 Capital Advisors, Inc. | 1.0% | ||||
| Steven A. Cohen | 1.0% | ||||
|
Vera Therapeutics, Inc.
13G
VERA · 92337R101
|
1.7% |
4/1/2026
Event 3/25/2026
|
|||
| Point72 Asset Management, L.P. | 1.7% | ||||
| Point72 Capital Advisors, Inc. | 1.7% | ||||
| Steven A. Cohen | 1.7% | ||||
|
Korro Bio, Inc.
13G
KRRO · 500946108
|
5.7% |
3/11/2026
Event 3/10/2026
|
|||
| Point72 Asset Management, L.P. | 3.7% | ||||
| Point72 Capital Advisors, Inc. | 3.7% | ||||
| Point72 Biotech Private Investments, LLC | 1.9% | ||||
| Differentiated Ventures Investments, LLC | 1.9% | ||||
| 72 Investment Holdings, LLC | 1.9% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Celldex Therapeutics, Inc.
13G/A
Amendment 1
CLDX · 15117B202
|
2.6% |
3/10/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 2.6% | ||||
| Point72 Capital Advisors, Inc. | 2.6% | ||||
| Steven A. Cohen | 2.6% | ||||
|
Edesa Biotech, Inc.
13G
EDSA · 27966L306
|
7.2% |
3/3/2026
Event 2/24/2026
|
|||
| Point72 Asset Management, L.P. | 7.2% | ||||
| Point72 Capital Advisors, Inc. | 7.2% | ||||
| Steven A. Cohen | 7.2% | ||||
|
Beta Bionics, Inc.
13G
BBNX · 08659B102
|
5.2% |
2/23/2026
Event 2/18/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Q32 Bio Inc.
13G
QTTB · 746964105
|
9.9% |
2/19/2026
Event 2/17/2026
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
OKYO Pharma Ltd
13G
OKYO · G6724L116
|
7.9% |
2/18/2026
Event 2/17/2026
|
|||
| Point72 Asset Management, L.P. | 7.9% | ||||
| Point72 Capital Advisors, Inc. | 7.9% | ||||
| Steven A. Cohen | 7.9% | ||||
|
Century Therapeutics, Inc.
13G/A
Amendment 1
IPSC · 15673T100
|
6.8% |
2/17/2026
Event 12/23/2025
|
|||
| Point72 Asset Management, L.P. | 6.8% | ||||
| Point72 Capital Advisors, Inc. | 6.8% | ||||
| Steven A. Cohen | 6.8% | ||||
|
Dianthus Therapeutics, Inc. /DE/
13G/A
Amendment 1
DNTH · 252828108
|
6.9% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.9% | ||||
| Point72 Capital Advisors, Inc. | 6.9% | ||||
| Steven A. Cohen | 6.9% | ||||
|
Kodiak Sciences Inc.
13G/A
Amendment 1
KOD · 50015M109
|
3.5% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 3.5% | ||||
| Point72 Capital Advisors, Inc. | 3.5% | ||||
| Steven A. Cohen | 3.5% | ||||
|
Wolfspeed, Inc.
13G/A
Amendment 1
WOLF · 97785W106
|
3.8% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 3.8% | ||||
| Point72 Capital Advisors, Inc. | 3.8% | ||||
| Steven A. Cohen | 3.8% | ||||
|
ADC Therapeutics SA
13G/A
Amendment 1
ADCT · H0036K147
|
4.0% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 4.0% | ||||
| Point72 Capital Advisors, Inc. | 4.0% | ||||
| Steven A. Cohen | 4.0% | ||||
|
Verastem, Inc.
13G/A
Amendment 1
VSTM · 92337C203
|
1.3% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 1.3% | ||||
| Point72 Capital Advisors, Inc. | 1.3% | ||||
| Steven A. Cohen | 1.3% | ||||
|
Avalo Therapeutics, Inc.
13G/A
Amendment 2
AVTX · 05338F306
|
3.5% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 3.5% | ||||
| Point72 Capital Advisors, Inc. | 3.5% | ||||
| Steven A. Cohen | 3.5% | ||||
|
Confluent, Inc.
13G/A
Amendment 2
CFLT · 20717M103
|
0.1% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 0.1% | ||||
| Point72 Capital Advisors, Inc. | 0.1% | ||||
| Steven A. Cohen | 0.1% | ||||
|
Cidara Therapeutics, Inc.
13G/A
Amendment 3
CDTX · 171757206
|
1.4% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 1.4% | ||||
| Point72 Capital Advisors, Inc. | 1.4% | ||||
| Steven A. Cohen | 1.4% | ||||
|
FG Nexus Inc.
13G/A
Amendment 2
FGNX · 30329Y304
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 7
PRAX · 74006W207
|
6.1% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.9% | ||||
| Point72 Capital Advisors, Inc. | 5.9% | ||||
| Point72 Biotech Private Investments, LLC | 0.3% | ||||
| Differentiated Ventures Investments, LLC | 0.3% | ||||
| 72 Investment Holdings, LLC | 0.3% | ||||
| Steven A. Cohen | 6.1% | ||||
|
PagSeguro Digital Ltd.
13G/A
Amendment 6
PAGS · G68707101
|
3.8% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 3.8% | ||||
| Point72 Capital Advisors, Inc. | 3.8% | ||||
| Steven A. Cohen | 3.8% | ||||
|
Alto Neuroscience, Inc.
13G/A
Amendment 3
ANRO · 02157Q109
|
8.9% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.8% | ||||
| Point72 Capital Advisors, Inc. | 6.8% | ||||
| Point72 Biotech Private Investments, LLC | 2.1% | ||||
| Differentiated Ventures Investments, LLC | 2.1% | ||||
| 72 Investment Holdings, LLC | 2.1% | ||||
| Steven A. Cohen | 8.9% | ||||
|
Korro Bio, Inc.
13G/A
Amendment 3
KRRO · 500946108
|
2.9% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Point72 Biotech Private Investments, LLC | 2.9% | ||||
| Differentiated Ventures Investments, LLC | 2.9% | ||||
| 72 Investment Holdings, LLC | 2.9% | ||||
| Steven A. Cohen | 2.9% | ||||
|
Pliant Therapeutics, Inc.
13G/A
Amendment 1
PLRX · 729139105
|
0.1% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 0.1% | ||||
| Point72 Capital Advisors, Inc. | 0.1% | ||||
| Steven A. Cohen | 0.1% | ||||
|
Palisade Bio, Inc.
13G/A
Amendment 1
PALI · 696389402
|
7.0% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 7.0% | ||||
| Point72 Capital Advisors, Inc. | 7.0% | ||||
| Steven A. Cohen | 7.0% | ||||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 1
IDYA · 45166A102
|
2.1% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 2.1% | ||||
| Point72 Capital Advisors, Inc. | 2.1% | ||||
| Steven A. Cohen | 2.1% | ||||
|
Design Therapeutics, Inc.
13G/A
Amendment 1
DSGN · 25056L103
|
9.4% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 9.4% | ||||
| Point72 Capital Advisors, Inc. | 9.4% | ||||
| Steven A. Cohen | 9.4% | ||||
|
Wolverine World Wide Inc /DE/
13G/A
Amendment 2
WWW · 978097103
|
1.5% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 1.5% | ||||
| Point72 Capital Advisors, Inc. | 1.5% | ||||
| Steven A. Cohen | 1.5% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
6.8% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.8% | ||||
| Point72 Capital Advisors, Inc. | 6.8% | ||||
| Steven A. Cohen | 6.8% | ||||
|
Invivyd, Inc.
13G/A
Amendment 2
IVVD · 00534A102
|
6.0% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.0% | ||||
| Point72 Capital Advisors, Inc. | 6.0% | ||||
| Steven A. Cohen | 6.0% | ||||
|
Aptevo Therapeutics Inc.
13G/A
Amendment 1
APVO · 03835L504
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
IO Biotech, Inc.
13G
IOBTQ · 449778109
|
5.6% |
2/6/2026
Event 2/5/2026
|
|||
| Point72 Asset Management, L.P. | 5.6% | ||||
| Point72 Capital Advisors, Inc. | 5.6% | ||||
| Steven A. Cohen | 5.6% | ||||
|
Precigen, Inc.
13G
PGEN · 74017N105
|
5.2% |
1/23/2026
Event 1/22/2026
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Infinite Eagle Acquisition Corp.
13G
IEAGU · G4802J129
|
5.8% |
1/21/2026
Event 1/20/2026
|
|||
| Point72 Asset Management, L.P. | 5.8% | ||||
| Point72 Capital Advisors, Inc. | 5.8% | ||||
| Steven A. Cohen | 5.8% | ||||
|
Forte Biosciences, Inc.
13G
FBRX · 34962G208
|
6.3% |
1/20/2026
Event 1/12/2026
|
|||
| Point72 Asset Management, L.P. | 6.3% | ||||
| Point72 Capital Advisors, Inc. | 6.3% | ||||
| Steven A. Cohen | 6.3% | ||||
|
KalVista Pharmaceuticals, Inc.
13G/A
Amendment 1
KALV · 483497103
|
5.5% |
1/13/2026
Event 1/5/2026
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Steven A. Cohen | 5.5% | ||||
|
KalVista Pharmaceuticals, Inc.
13G
KALV · 483497103
|
4.9% |
1/12/2026
Event 1/5/2026
|
|||
| Point72 Asset Management, L.P. | 4.9% | ||||
| Point72 Capital Advisors, Inc. | 4.9% | ||||
| Steven A. Cohen | 4.9% | ||||